Controlling wound bioburden with a novel silver-containing Hydrofiber® dressing

Wound Repair and Regeneration

Volumn 12, Issue 3, 2004, Pages 288-294

  Jones, Samantha A ^a   Bowler, Philip G ^a   Walker, Michael ^a   Parsons, David ^a  

^a Deeside Industrial Estate   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; SILVER; TOXIN;

AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BODY BURDEN; DEVICE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL GROWTH; PRIORITY JOURNAL; TISSUE DEGENERATION; WOUND DRESSING; WOUND HEALING;

ADMINISTRATION, TOPICAL; ANTI-BACTERIAL AGENTS; BACTERIA; CARBOXYMETHYLCELLULOSE; COLONY COUNT, MICROBIAL; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; OCCLUSIVE DRESSINGS; SILVER; WOUND INFECTION;

EID: 3042777108     PISSN: 10671927     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1067-1927.2004.012304.x     Document Type: Article

References (36)

1. Bowler P. The anaerobic and aerobic microbiology of wounds: a review. Wounds 1998;10:170-8.
2. Bowler PG, Duerden BI, Armstrong DG. Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 2001;14:244-69.
3. White R, Cooper R, Kingsley A. Wound colonization and infection: the role of topical antimicrobials and guidelines in management. Br J Nurs 2001;10:563-78.
4. Robson MC. Wound infection. A failure of wound healing caused by an imbalance of bacteria. Surg Clin North Am 1997;77:637-50.
5. EPUAP. European Pressure Ulcer Advisory Panel. Guidelines on the treatment of pressure ulcers. EPUAP Rev 1999;1:31-3.
6. Normark BH, Normark S. Evolution and spread of antibiotic resistance. J Intern Med 2002;252:91-106.
7. Hueston WJ, Dickerson L. Antibiotic resistance and the need for the rational use of antibiotics. J Med Liban 2001;49:246-56.
8. Lawrence JC. The use of iodine as an antiseptic agent. J Wound Care 1998;7:421-5.
9. Lansdown ABG. Silver 1: its antimicrobial properties and mechanism of action. J Wound Care 2002;11:125-30.
10. Demling RH, DeSanti L. Effects of silver on wound management. Wounds 2001;13 (Suppl A):A3-A15.
11. Cutting KF. A dedicated follower of fashion? Topical medications and wounds. Br J Nurs 2001;10:9-16.
12. Thomas S, McCubbin P. A comparison of the antimicrobial effects of four silver-containing dressings on three organisms. J Wound Care 2003;12:101-7.
13. Field FK, Kerstein MD. Overview of wound healing in a moist environment. Am J Surg 1994;167(1A):2S-6S.
14. Armstrong SH, Ruckley CV. Use of a fibrous dressing in exuding leg ulcers. J Wound Care 1997;6:322-4.
15. Harding KG, Price P, Robinson B, Thomas S, Hofman D. Cost and dressing evaluation of hydrofiber and alginate dressings in the management of community-based patients with chronic leg ulceration. Wounds 2001;13:229-36.
16. Lydon MJ. The development of Aquacel Hydrofiber dressings. In: Krieg, T Harding, KG, editors. Aquacel Hydrofiber dressing: the next step in wound dressing technology. Proceedings of a Satellite Symposium at the Sixth Congress of the European Academy of Dermatology and Venereology; 1997 Sept 11-15; Dublin, Ireland. London: Churchill Communications, 1998:1-3.
17. Wright JB, Hansen DL, Burrell RE. The comparative efficacy of two antimicrobial barrier dressings: in vitro examination of two controlled release silver dressings. Wounds 1998;10:179-88.
18. Heggers JP. Defining infection in chronic wounds: methodology. J Wound Care 1998;7:452-6.
19. Duerden BI. Virulence factors in anaerobes. Clin Infect Dis 1994;18 (Suppl 4):S253-9.
20. Steffen EK, Hentges DJ. Hydrolytic enzymes of anaerobic bacteria isolated from human infections. J Clin Microbiol 1981;14:153-6.
21. Morgan M, Evans-Williams D, Salmon R, Hosein I, Looker DN, Howard A. The population impact of MRSA in a country: the national survey of MRSA in Wales, 1997. J Hosp Infect 2000; 44:227-39.
22. Wright JB, Lam K, Burrell RE. Wound management in an era of increasing bacterial antibiotic resistance: a role for topical silver treatment. Am J Infect Control 1998;26:572-7.
23. Lawrence JC. Dressings and wound infection. Am J Surg 1994;167 (1A):21S-4S.
24. Lawrence JC, Lilly HA, Kidson A. Wound dressings and airborne dispersal of bacteria. Lancet 1992;339:807.
25. Ovington LG. Hanging wet-to-dry dressings out to dry. Home Healthc Nurse 2001;19:477-83.
26. Bolton L, van Rijswijk L. Cost effective wound care. CAET J 1999;18:23-5.
27. Greene RM, Su WP. Argyria. Am Fam Physician 1987;36:151-4.
28. Klein DG, Fritsch DE, Amin SG. Wound infection following trauma and burn injuries. Crit Care Nurs Clin North Am 1995; 7:627-42.
29. Hoekstra MJ, Hupkens P, Dutrieux RP, Bosch MM, Brans TA, Kreis RW. A comparative bum wound model in the New York-shire pig for the histopathological evaluation of local therapeutic regimens: silver sulfadiazine cream as a standard. Br J Plast Surg 1993;46:585-9.
30. Foster L, Moore P, Clark S. A comparison of hydrofibre and alginate dressings on open acute surgical wounds. J Wound Care 2000;9:442-5.
31. Vloemans AF, Soesman AM, Kreis RW, Middelkoop E. A newly developed hydrofibre dressing, in the treatment of partial-thickness burns. Burns 2001;27:167-73.
32. Silver S, Novick R, Gupta A. Mechanisms of resistance to heavy metals and quaternary amines. In: Fischetti, VA, Novick, RP, Ferretti, JJ, Portnoy, D, Rood, JI, editors. Gram positive pathogens. Washington, DC: ASM Press, 2000.
33. Williams C. An investigation of the benefits of Aquacel Hydrofiber wound dressing. Br J Nurs 1999;8:676-7, 80.
34. Bowler PG, Jones SA, Walker M, Parsons D. The microbicidal properties of a silver-containing Hydrofiber® dressing against a variety of common burn wound pathogens. J Burn Care Rehab 2004;25:192-6.
35. Robinson BJ. The use of a hydrofibre dressing in wound management. J Wound Care 2000;9:32-4.
36. Plowman R. The socio-economic burden of hospital-acquired infection: executive summary. London: Public Health Laboratory Service, 1999.